ArticleNeurosurgical review2025
Establishing a policy statement on the use of artificial intelligence in neurosurgery.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence and the future of clinical trials.Contemporary clinical trials communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Throughout the past decade, artificial intelligence (AI) has evolved from theoretical use to practical application in various medical specialties including neurosurgery. Given the increasing interest and exploration of AI models at national neurosurgical conferences, outlining policy for the appropriate and ethical use of AI in neurosurgery is warranted. To this end, the Council of State Neurosurgical Societies (CSNS) Workforce Committee convened an ad hoc committee to explore AI in neurosurgery following passage of a resolution at the 2024 fall meeting (Resolution II-2024 F). This editorial discusses the development process, guiding principles, and supporting evidence behind the AI policy statement. The committee conducted a thorough review of current AI tools, their applications, and their potential pitfalls. A review of existing policies from professional bodies was also conducted. The resulting policy emphasizes five core domains based on the committee's findings and the need for structured guidance in those areas. These included responsible use, privacy and security, transparency, academic integrity, and financial conflicts. The committee also conducted original investigations to explore the efficacy of AI use in certain domains that were under explored in the literature, particularly in academics, to inform key positions.
Indexed as
Identifiers
40825884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.